223 related articles for article (PubMed ID: 36266640)
1. Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto's thyroiditis.
Zhang Y; Tian Y
BMC Endocr Disord; 2022 Oct; 22(1):252. PubMed ID: 36266640
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram.
Chen F; Li Z; Deng C; Yan H
J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223
[TBL] [Abstract][Full Text] [Related]
3. Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto's thyroiditis using bioinformatics methods.
Liu TT; Yin DT; Wang N; Li N; Dong G; Peng MF
Front Endocrinol (Lausanne); 2023; 14():1140094. PubMed ID: 37324256
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer.
Liu C; Pan Y; Li Q; Zhang Y
Int J Med Sci; 2021; 18(15):3478-3487. PubMed ID: 34522174
[No Abstract] [Full Text] [Related]
5. Identification of
Zhang Y; Xie X; Zhou H; Li B; Ding L; Cai Z; Song H; Zhao S; Xu H
Front Endocrinol (Lausanne); 2023; 14():1131078. PubMed ID: 37455914
[TBL] [Abstract][Full Text] [Related]
6. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
[No Abstract] [Full Text] [Related]
7. Clinicopathological characterization and prognostic implication of FOXP3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.
Mohamed SY; Ibrahim TR; Elbasateeny SS; Abdelaziz LA; Farouk S; Yassin MA; Embaby A
Sci Rep; 2020 Jun; 10(1):10651. PubMed ID: 32606302
[TBL] [Abstract][Full Text] [Related]
8. Construction and analysis of an aberrant lncRNA-miRNA-mRNA network associated with papillary thyroid cancer.
Jiang Y; Wang J; Chen J; Wang J; Xu J
Medicine (Baltimore); 2020 Nov; 99(45):e22705. PubMed ID: 33157921
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Liu Y; Lv H; Zhang S; Shi B; Sun Y
Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
[TBL] [Abstract][Full Text] [Related]
10. Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis.
Subhi O; Schulten HJ; Bagatian N; Al-Dayini R; Karim S; Bakhashab S; Alotibi R; Al-Ahmadi A; Ata M; Elaimi A; Al-Muhayawi S; Mansouri M; Al-Ghamdi K; Hamour OA; Jamal A; Al-Maghrabi J; Al-Qahtani MH
PLoS One; 2020; 15(6):e0234566. PubMed ID: 32603365
[TBL] [Abstract][Full Text] [Related]
11. Interaction of BANCR in the relationship between Hashimoto's thyroiditis and papillary thyroid carcinoma expression patterns and possible molecular mechanisms.
Zhang J; Yao L; Guo Y
J Gene Med; 2024 Feb; 26(2):e3663. PubMed ID: 38342961
[TBL] [Abstract][Full Text] [Related]
12. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
Zhao Y; Wang H; Wu C; Yan M; Wu H; Wang J; Yang X; Shao Q
Oncol Rep; 2018 Mar; 39(3):1197-1206. PubMed ID: 29328463
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Pathological Characteristics of Patients With Papillary Thyroid Carcinoma Coexisting With Hashimoto's Thyroiditis: A Retrospective Cohort Study.
Yang Y; Liu J; Shi X; Wang M
Cancer Control; 2023; 30():10732748231199647. PubMed ID: 37643366
[TBL] [Abstract][Full Text] [Related]
14. A novel lncRNA-miRNA-mRNA network analysis identified the hub lncRNA RP11-159F24.1 in the pathogenesis of papillary thyroid cancer.
Jiang W; Zhan H; Jiao Y; Li S; Gao W
Cancer Med; 2018 Dec; 7(12):6290-6298. PubMed ID: 30474931
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Impact of BRAF mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto's thyroiditis: a systematic review with meta-analysis.
Janicki L; Patel A; Jendrzejewski J; Hellmann A
Front Endocrinol (Lausanne); 2023; 14():1273498. PubMed ID: 38047109
[TBL] [Abstract][Full Text] [Related]
16. IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis.
Lu ZW; Hu JQ; Liu WL; Wen D; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32348468
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of lncRNA-mediated ceRNA network in papillary thyroid cancer.
Sun Y; Dai WR; Xia N
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10003-10014. PubMed ID: 33090405
[TBL] [Abstract][Full Text] [Related]
18. Identification of Long Noncoding RNAs Associated With the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated With Hashimoto's Thyroiditis.
Zhang Y; Lu KN; Ding JW; Peng Y; Pan G; Teng LS; Luo DC
Front Oncol; 2022; 12():766016. PubMed ID: 35359359
[TBL] [Abstract][Full Text] [Related]
19. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
[TBL] [Abstract][Full Text] [Related]
20. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
Liang J; Zeng W; Fang F; Yu T; Zhao Y; Fan X; Guo N; Gao X
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
